Odonate Therapeutics
Odonate, Inc., has no significant operations. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
Market Cap & Net Worth: Odonate Therapeutics (ODTC)
Odonate Therapeutics (PINK:ODTC) has a market capitalization of $17.80 Million ($17.80 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #29607 globally and #9802 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Odonate Therapeutics's stock price $50000.00 by its total outstanding shares 356 (356.00).
Odonate Therapeutics Market Cap History: 2017 to 2025
Odonate Therapeutics's market capitalization history from 2017 to 2025. Data shows growth from $44.50K to $17.80 Million (129.65% CAGR).
Odonate Therapeutics Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Odonate Therapeutics's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ODTC by Market Capitalization
Companies near Odonate Therapeutics in the global market cap rankings as of March 19, 2026.
Key companies related to Odonate Therapeutics by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Odonate Therapeutics Historical Marketcap From 2017 to 2025
Between 2017 and today, Odonate Therapeutics's market cap moved from $44.50K to $ 17.80 Million, with a yearly change of 129.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $17.80 Million | +193.26% |
| 2024 | $6.07 Million | +227233.33% |
| 2023 | $2.67K | -14.29% |
| 2022 | $3.12K | +29.63% |
| 2021 | $2.40K | -92.97% |
| 2020 | $34.18K | -40.83% |
| 2019 | $57.76K | +130.47% |
| 2018 | $25.06K | -43.68% |
| 2017 | $44.50K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Odonate Therapeutics was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.80 Million USD |
| MoneyControl | $17.80 Million USD |
| MarketWatch | $17.80 Million USD |
| marketcap.company | $17.80 Million USD |
| Reuters | $17.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.